Navigation Links
AEterna Zentaris Presents Two Posters on its PI3K Inhibitor Compound, AEZS-126, at AACR Annual Meeting
Date:4/21/2009

In Vitro and In Vivo Data Show AEZS-126 as Promising Oral Compound for

Future Clinical Development in Cancer

QUEBEC CITY, April 21 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (TSX: AEZ; NASDAQ: AEZS), a global biopharmaceutical company focused on endocrine therapy and oncology, today presented two posters on AEZS-126, a promising compound for clinical intervention of the PI3K/ Akt pathway in human tumors. The posters were presented at the American Association for Cancer Research (AACR) Annual Meeting in Denver, Colorado.

Poster #3705

Entitled, "AEZS-126, a new orally bioavailable PI3K inhibitor with antitumor effects", I. Seipelt, S. Baasner, M. Gerlach, M. Teifel, J. Fensterle, L. Blumenstein, G. Mueller and E. Guenther, the poster focuses on ADMET and safety profiling of the compound, as well as in vivo pharmacokinetic experiments and mouse xenograft antitumor studies.

Results

AEZS-126 was identified as a potent inhibitor of class I PI3Ks in biochemical and cellular assays and demonstrated favorable properties in early in vitro ADMET screening including microsomal stability, plasma stability and screening against a large safety profile composed of receptors, enzymes and cardiac ion-channels. During the course of in vivo pharmacokinetic experiments and mouse xenograft antitumor studies, the oral bioavailability in mice was determined to be about 60%, leading to micromolar plasma levels which are well above the nanomolar IC50 values in in vitro studies. Significant antitumor activity was observed at 30mg/kg daily oral administration in Hct116 and A549 models.

Conclusion

These data suggest that AEZS-126 is a promising compound for clinical intervention of the PI3K/Akt pathway in human tumors.

Poster #3706

'/>"/>
SOURCE AETERNA ZENTARIS INC.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
2. AEterna Zentaris to Present at Upcoming UBS Global Life Sciences Conference in New York
3. AEterna Zentaris Announces Outcome of Managements Strategic Review
4. AEterna Zentaris to Further Develop Three Follow-up Multi-targeted Cytotoxic Candidates to AEZS-112 as Potential Novel Cancer Treatment
5. AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers
6. AEterna Zentaris to Present at the Upcoming Roth Capital Partners 20th Annual OC Growth Stock Conference in Dana Point, California
7. Aeterna Zentaris to Announce Fourth Quarter and Full-Year 2007 Financial and Operating Results on March 5, 2008
8. AEterna Zentaris Announces the Departure of SVP, Administrative and Legal Affairs
9. AEterna Zentaris and Paladin Labs Announce Sale and Purchase of Miltefosine Rights
10. Aeterna Zentaris Reports Fourth Quarter and Full-Year 2007 Financial and Operating Results
11. Aeterna Zentaris Begins Second Phase 3 Trial of Cetrorelix for Benign Prostatic Hyperplasia

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...wswire/ -- Reportlinker.com announces that a new m...e: ,, Industrial Enzymes - A Global Market Rep...ndustrial-Enzymes---A-Global-Market-Report.html ,...h few strong players and a host of small suppliers...ion and commoditization characterize the industry....
(Date:12/1/2009).... 1 To address the emergence of th...tential, a group of individuals and companies anno...try Association (SynBIA) in Cambridge, Massachuset...ovide a forum for individuals and commercial inter...rtunities and its challenges, and advocate for its...
(Date:12/1/2009)...Newswire/ -- Expanding its European reach for bact...a has appointed Lake Chemicals and Minerals of Eng... Birmingham, England. ,, Osprey breeds trillio...ural, waste water, and environmental markets. Its ...ields, and clean up industrial and marine spills. ...
(Date:12/1/2009)...el storage is now available to small and medium si...k. , (PRWEB) December 1, ... medical imaging software company, announced the r...vice. The PacsDrive service enables small and medi... medical imaging in compliance with HIPAA regulati...
Breaking Biology Technology:Reportlinker Adds Industrial Enzymes - A Global Market Report 2Reportlinker Adds Industrial Enzymes - A Global Market Report 3Reportlinker Adds Industrial Enzymes - A Global Market Report 4Reportlinker Adds Industrial Enzymes - A Global Market Report 5Reportlinker Adds Industrial Enzymes - A Global Market Report 6Reportlinker Adds Industrial Enzymes - A Global Market Report 7Reportlinker Adds Industrial Enzymes - A Global Market Report 8Reportlinker Adds Industrial Enzymes - A Global Market Report 9Reportlinker Adds Industrial Enzymes - A Global Market Report 10Industry Forms Association to Address Opportunities and Challenges of Synthetic Biology 2PacsDrive Announces Low Cost Medical Imaging Storage Service, Seeks to Alter Status Quo in Health Care IT 2
...GN, Ill. Detecting deadly fumes in subways, toxic...n baggage is becoming easier and more efficient wi... Raman scattering. To further improve the techniqu...ttering surfaces, and more effective ways of evalu...inois, led by chemistry professor Dana Dlott, have...
...ave worked for almost seven years in secret. , Mo...r,s materials characterization department at Sandi... information to the FBI,s investigation of letters...use the disease anthrax. The spores were mailed in...d to two U.S. senators. Five people were killed. ,...
... Brazil, Sept. 23 A bill designed to,strengthen e...ved today by,the U.S. Senate Foreign Relations Com...rts by Brazil and the United States to promote the...hout Latin America, according to the,Brazilian Sug... clear desire by the U.S. Congress for a positive ...
Other Biology Technology:Killer pulses help characterize special surfaces 2FBI unveils science of anthrax investigation 2FBI unveils science of anthrax investigation 3New Bill to Expand Promotion of Biofuels Is a Welcome Boost for U.S.-Brazil Relations According to Brazilian Sugarcane Industry 2New Bill to Expand Promotion of Biofuels Is a Welcome Boost for U.S.-Brazil Relations According to Brazilian Sugarcane Industry 3
(Date:12/1/2009)...rly in Alzheimer,s disease, nerve cell degeneratio...utic options may possibly be derived from steering...findings have been published in the current issue ...il only a few years ago, neurogenesis the process...mpossible in the adult brain. The textbooks assert...
(Date:12/1/2009)...rgia Institute of Technology has been awarded a U....ructures for energy harvesting and adaptive materi...nitive processes of the modern warfighter. , Th...led Inorganic/Organic Nanostructures and Improved ...r Tsukruk and Kenneth Sandhage, professors in Geor...
(Date:12/1/2009)...LE, Fla. Hit-and-run attacks by sharks can be sol...its by the unique chomp they put on their victims,...nd shark expert. , In a method analogous to anal...tifications by precisely comparing shark bites to ... George Burgess, director of the International Sha...
Breaking Biology News(10 mins):New source discovered for the generation of nerve cells in the brain 2Air Force Center of Excellence awarded in nanostructures and improved cognition 2Air Force Center of Excellence awarded in nanostructures and improved cognition 3Air Force Center of Excellence awarded in nanostructures and improved cognition 4New forensic technique gives clues about sharks from bite damage 2New forensic technique gives clues about sharks from bite damage 3Technology Review names Carnegie Mellons Treuille as a top young innovator 9608 1Technology Review names Carnegie Mellons Treuille as a top young innovator 9608 2Consumer Driven Health Plans Surpass HMOs in Popularity With Employees 54697 1Consumer Driven Health Plans Surpass HMOs in Popularity With Employees 54697 2Consumer Driven Health Plans Surpass HMOs in Popularity With Employees 54697 3Consumer Driven Health Plans Surpass HMOs in Popularity With Employees 54697 4Consumer Driven Health Plans Surpass HMOs in Popularity With Employees 54697 5UGA UPR grant license for long persistence glow materials in any color 13598 1UGA UPR grant license for long persistence glow materials in any color 13598 2UGA UPR grant license for long persistence glow materials in any color 13598 3UGA UPR grant license for long persistence glow materials in any color 13598 4
...London, ON A new technology that could help physi...a prenatal and potentially fatal complication call...ty of Western Ontario and the Children,s Health Re...te. , The technology, employing a panel of biomar...of women who develop preeclampsia, has been licens...
...OAK RIDGE, Tenn. Dec. 18, 2008 -- In 2009, Oak Rid...n processor hours available on Jaguar, its Cray XT...nnovative and Novel Computational Impact on Theory...ght separate projects will advance breakthrough re...energy assurance, materials, and other areas of fu...
... This release is available in German . , A re...llizzeri from the Max Planck Institute for Radio A...cope to detect water at the greatest distance from...the quasar MG J0414+0534 at redshift 2.64, which c...years, a time when the Universe was only a fifth o...
Other Biology News:New technology aims to reduce maternal and neonatal deaths 22009 DOE INCITE projects allocated at ORNL 22009 DOE INCITE projects allocated at ORNL 3Water in the early universe 2Water in the early universe 3
Sf9 Insect Cells from BD Biosciences Pharmingen
Auto/Zyme Reagent Set from Biomeda Corporation
Anti-rat Ig HRP detection kit from BD Biosciences Pharmingen
Agarose, high gelling temperature, Molecular Biology Grade from Research Organics, Inc.
Biology Products: